Skip to main content
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1979 Jun;38(3):271–278. doi: 10.1136/ard.38.3.271

Effect of oral D-penicillamine treatment on experimental arthritis and associated immune responses in rabbits. III: Reduction of the monoarticular arthritis.

I M Hunneyball, G A Stewart, D R Stanworth
PMCID: PMC1000450  PMID: 290353

Abstract

Treatment of rabbits with D-penicillamine at doses up to 30 mg/kg, beginning either before or after the onset of antigen-induced experimental arthritis, diminished the severity of the inflammatory synovitis in a considerable proportion of animals as judged by both external joint measurements and terminal histopathological assessment. D-penicillamine treatment had no effect on serum haptoglobin concentration, haemoglobin concentration, or platelet count. The venous blood white cell count was raised when D-penicillamine treatment was started before immunisation but not when treatment began after the onset of arthritis. A transient loss of appetite was observed in animals starting D-penicillamine treatment.

Full text

PDF
271

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blackham A., Radziwonik H. The effect of drugs in established rabbit monoarticular arthritis. Agents Actions. 1977 Oct;7(4):473–480. doi: 10.1007/BF01966856. [DOI] [PubMed] [Google Scholar]
  2. Consden R., Doble A., Glynn L. E., Nind A. P. Production of a chronic arthritis with ovalbumin. Its retention in the rabbit knee joint. Ann Rheum Dis. 1971 May;30(3):307–315. doi: 10.1136/ard.30.3.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Constable T. J., Crockson R. A., Crockson A. P., McConkey B. Drug treatment of rheumatoid arthritis. A systematic approach. Lancet. 1975 May 24;1(7917):1176–1180. doi: 10.1016/s0140-6736(75)93150-5. [DOI] [PubMed] [Google Scholar]
  4. DUMONDE D. C., GLYNN L. E. The production of arthritis in rabbits by an immunological reaction to fibrin. Br J Exp Pathol. 1962 Aug;43:373–383. [PMC free article] [PubMed] [Google Scholar]
  5. Day A. T., Golding J. R., Lee P. N., Butterworth A. D. Penicillamine in rheumatoid disease: a long-term study. Br Med J. 1974 Feb 2;1(5900):180–183. doi: 10.1136/bmj.1.5900.180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Glynn L. E. The chronicity of inflammation and its significance in rheumatoid arthritis. Ann Rheum Dis. 1968 Mar;27(2):105–121. doi: 10.1136/ard.27.2.105. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Goldberg V. M., Lance E. M., Davis P. Experimental immune synovitis in the rabbit. Relative roles of cell mediated and humoral immunity. Arthritis Rheum. 1974 Nov-Dec;17(6):993–1005. doi: 10.1002/art.1780170612. [DOI] [PubMed] [Google Scholar]
  8. Hunneyball I. M., Stewart G. A., Stanworth D. R. Effect of D(-)penicillamine on chronic experimental arthritis in rabbits. Ann Rheum Dis. 1977 Aug;36(4):378–380. doi: 10.1136/ard.36.4.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hunneyball I. M., Stewart G. A., Stanworth D. R. The effects of oral D-penicillamine treatment on experimental arthritis and the associated immune response in rabbits. II. The effects on cellular parameters. Immunology. 1978 Jul;35(1):159–166. [PMC free article] [PubMed] [Google Scholar]
  10. Hunneyball I. M., Stewart G. A., Stanworth D. R. The effects of oral D-penicillamine treatment on experimental arthritis and the associated immune response in rabbits. Immunology. 1978 Jun;34(6):1053–1061. [PMC free article] [PubMed] [Google Scholar]
  11. Huskisson E. C., Gibson T. J., Balme H. W., Berry H., Burry H. C., Grahame R., Hart F. D., Henderson D. R., Wojtulewski J. A. Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report. Ann Rheum Dis. 1974 Nov;33(6):532–535. doi: 10.1136/ard.33.6.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jaffe I. A. The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine. Arthritis Rheum. 1970 Jul-Aug;13(4):436–443. doi: 10.1002/art.1780130412. [DOI] [PubMed] [Google Scholar]
  13. Liyanage S. P., Currey H. L. Failure of oral D-penicillamine to modify adjuvant arthritis or immune response in the rat. Ann Rheum Dis. 1972 Nov;31(6):521–521. doi: 10.1136/ard.31.6.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Menard H. A., Dion J. Experimental immune arthritis: host factors. J Rheumatol. 1975 Dec;2(4):373–383. [PubMed] [Google Scholar]
  15. Püschel W., Rosenkranz M., Geiler G., Caffier B., Stiehl P., Richter V. Zur Wirkung von D-Penicillamin auf die experimentelle allergische Arthritis des Kaninchens. Z Rheumatol. 1976 May-Jun;35(5-6):201–209. [PubMed] [Google Scholar]
  16. RATCLIFF A. P., HARDWICKE J. ESTIMATION OF SERUM HAEMOGLOBIN-BINDING CAPACITY (HAPTOGLOBIN) ON SEPHADEX G.100. J Clin Pathol. 1964 Nov;17:676–679. doi: 10.1136/jcp.17.6.676. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES